At the Envision Summit 2025 in San Juan, Puerto Rico, Kelly Donovan, MD, talked about her graduate research on the earliest ...

Sexual harassment in the specialty remains high 5 years after a previous study, with higher frequencies of recent experiences ...

At the Envision Summit 2025 in San Juan, Puerto Rico, Oleg Alekseev, MD, PhD, talked about difficulties in diagnosing ...

At the Envision Summit 2025 in San Juan, Puerto Rico, Giulia Corradetti, MD discussed AI applications in the identification ...

Ying Han, MD, PhD discusses glaucoma management strategies, including transitioning care between ophthalmologists and ...

Patients who underwent bilateral treatment experienced a higher rate of clinically relevant recovery, the authors reported.

SightScore is a saliva test that looks at millions of genetic variants in the patient’s genome to create a personalized ...

At the Envision Summit 2025 in San Juan, Puerto Rico, Ollya Fromal, MD, gave advice on how retina specialists can manage ...

At the Envision Summit 2025 in San Juan, Puerto Rico, Sharon Fekrat, MD, FACS, FASRS talked about multi-modal retinal and ...

At the Envision Summit 2025 in San Juan, Puerto Rico, Rachel Simpson, MD, talked about new developments in glaucoma treatment ...

PST-611, a first in class non-viral vectorized therapy expressing human transferrin, a highly potent iron regulator.

The focus in recent years has shifted to reducing the long-term burden of medical therapy, minimizing the risk of medication ...